Advertisement
Screener

SECTOR GAMMA AS Historic Quarter Change: USA Other Stocks, Sold Out

SECTOR GAMMA AS historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, SECTOR GAMMA AS opened 28 positions, added to 52, reduced 43 and sold out of 39.

  • Q1 2025: Stock QIAGEN NV; Country of operation —; Class SHS NEW; Shares before 203,993.
  • Q1 2025: Stock TANDEM DIABETES CARE INC; Country of operation United States; Class COM NEW; Shares before 66,023.
  • Q1 2024: Stock LABORATORY CORP AMER HLDGS; Country of operation United States; Class COM NEW; Shares before 50,686.
  • Q1 2024: Stock QIAGEN NV; Country of operation —; Class SHS NEW; Shares before 190,539.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1475373), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-12); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-07); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-12); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-31); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-07-31); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-13); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-11); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-09); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-08); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-08); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-11); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-27); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-13); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-13); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-15); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-09); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-12-16). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-09-30. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2025QIAGEN NV
CUSIP N72482149
SHS NEW203,9930-203,993$9,083,808$0-$9,083,8082025-05-13
Q1 2025TANDEM DIABETES CARE INC
CUSIP 875372AB0
United StatesCOM NEW66,0230-66,023$2,378,148$0-$2,378,1482025-05-13
Q1 2024LABORATORY CORP AMER HLDGS
CUSIP 50540R409
United StatesCOM NEW50,6860-50,686$11,520,421$0-$11,520,4212024-05-08
Q1 2024QIAGEN NV
CUSIP N72482123
SHS NEW190,5390-190,539$8,275,109$0-$8,275,1092024-05-08
Q3 2016ST JUDE MED INC
CUSIP 790849103
COM258,2140-258,214$20,141,000$0-$20,141,0002016-11-08
Q2 2016MEDIVATION INC
CUSIP 58501N101
COM385,9230-385,923$17,745,000$0-$17,745,0002016-08-11
Q2 2016BAXALTA INC
CUSIP 07177M103
COM356,3100-356,310$14,395,000$0-$14,395,0002016-08-11
Q1 2016WELLCARE HEALTH PLANS INC
CUSIP 94946T106
COM99,8650-99,865$7,810,000$0-$7,810,0002016-05-27
Q4 2015RITE AID CORP
CUSIP 767754104
COM1,280,5000-1,280,500$7,773,000$0-$7,773,0002016-02-12
Q4 2015MEDICINES CO
CUSIP 584688105
COM112,7550-112,755$4,280,000$0-$4,280,0002016-02-12
Q3 2015THORATEC CORP
CUSIP 885175307
COM NEW229,3000-229,300$10,220,000$0-$10,220,0002015-11-16
Q2 2015LIFEPOINT HEALTH INC
CUSIP 53219L109
COM119,6980-119,698$8,792,000$0-$8,792,0002015-08-13
Q1 2015HOSPIRA INC
CUSIP 441060100
COM284,3000-284,300$17,413,000$0-$17,413,0002015-05-14
Q1 2015MYLAN INC
CUSIP 628530107
COM256,6000-256,600$14,465,000$0-$14,465,0002015-05-14
Q1 2015PATTERSON COMPANIES INC
CUSIP 703395103
United StatesCOM237,4650-237,465$11,422,000$0-$11,422,0002015-05-14
Q1 2015ACORDA THERAPEUTICS INC
CUSIP 00484M106
COM84,9000-84,900$3,470,000$0-$3,470,0002015-05-14
Q4 2014CUBIST PHARMACEUTICALS INC
CUSIP 229678107
COM199,9900-199,990$13,267,000$0-$13,267,0002015-02-17
Q4 2014VOLCANO CORPORATION
CUSIP 928645100
COM557,0000-557,000$5,926,000$0-$5,926,0002015-02-17
Q4 2014CATAMARAN CORP
CUSIP 148887102
COM113,5000-113,500$4,784,000$0-$4,784,0002015-02-17
Q4 2014ALLERGAN INC
CUSIP 018490102
COM20,0000-20,000$3,564,000$0-$3,564,0002015-02-17
Q4 2014AVANIR PHARMACEUTICALS INC
CUSIP 05348P401
CL A NEW229,4000-229,400$2,734,000$0-$2,734,0002015-02-17
Q4 2014AUXILIUM PHARMACEUTICALS INC
CUSIP 05334D107
COM85,9200-85,920$2,565,000$0-$2,565,0002015-02-17
Q2 2014WELLCARE HEALTH PLANS INC
CUSIP 94946T106
COM194,7000-194,700$12,367,000$0-$12,367,0002014-08-15
Q2 2014VOLCANO CORPORATION
CUSIP 928645100
COM475,9000-475,900$9,380,000$0-$9,380,0002014-08-15
Q2 2014EXPRESS SCRIPTS INC
CUSIP 30219G108
COM86,7000-86,700$6,510,000$0-$6,510,0002014-08-15
Q2 2014VIVUS INC
CUSIP 928551100
COM40,0000-40,000$238,000$0-$238,0002014-08-15
Q1 2014FOREST LABS INC
CUSIP 345838106
COM440,3490-440,349$26,434,000$0-$26,434,0002014-05-09
Q1 2014ST JUDE MED INC
CUSIP 790849103
COM106,0000-106,000$6,567,000$0-$6,567,0002014-05-09
Q1 2014ALLERGAN INC
CUSIP 018490102
COM45,0000-45,000$4,999,000$0-$4,999,0002014-05-09
Q1 2014HEALTH NET INC
CUSIP 42222G108
COM145,0000-145,000$4,302,000$0-$4,302,0002014-05-09
Q1 2014MOMENTA PHARMACEUTICALS INC
CUSIP 60877T100
COM136,8000-136,800$2,419,000$0-$2,419,0002014-05-09
Q4 2013ONYX PHARMACEUTICALS INC
CUSIP 683399109
COM103,2150-103,215$12,871,000$0-$12,871,0002014-02-14
Q4 2013WELLCARE HEALTH PLANS INC
CUSIP 94946T106
COM148,9000-148,900$10,384,000$0-$10,384,0002014-02-14
Q4 2013SALIX PHARMACEUTICALS INC
CUSIP 795435106
COM141,3010-141,301$9,450,000$0-$9,450,0002014-02-14
Q4 2013MALLINCKRODT PUB LTD CO
CUSIP G5785G107
SHS179,0000-179,000$7,892,000$0-$7,892,0002014-02-14
Q4 2013VOLCANO CORPORATION
CUSIP 928645100
COM312,7000-312,700$7,489,000$0-$7,489,0002014-02-14
Q4 2013OPTIMER PHARMACEUTICALS INC
CUSIP 68401H104
COM376,3930-376,393$4,739,000$0-$4,739,0002014-02-14
Q4 2013HOSPIRA INC
CUSIP 441060100
COM76,0000-76,000$2,981,000$0-$2,981,0002014-02-14
Q3 2013DENDREON CORP
CUSIP 24823Q107
COM345,0000-345,000$1,421,000$0-$1,421,0002013-12-16

Similar Firms

Firm NameCountry13F ValueHoldings
AMJ Financial Wealth ManagementUnited States$0.424B86
MCDONALD PARTNERS LLCUnited States$0.424B208
Dalal Street, LLCUnited States$0.423B3
Retirement Solution LLCUnited States$0.423B57
Dunhill Financial, LLCUnited Kingdom$0.424B1,857
OnyxPoint Global Management LPUnited States$0.424B29
CYPRESS POINT INVESTMENT MANAGEMENT LPUnited States$0.424B32
Midwest Professional Planners, LTD.United States$0.425B137
Shakespeare Wealth Management, LLCUnited States$0.422B100
Atlas Private Wealth AdvisorsUnited States$0.425B132